Correlation Between SeqLL and Transcode Therapeutics
Can any of the company-specific risk be diversified away by investing in both SeqLL and Transcode Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining SeqLL and Transcode Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between SeqLL Inc and Transcode Therapeutics, you can compare the effects of market volatilities on SeqLL and Transcode Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in SeqLL with a short position of Transcode Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of SeqLL and Transcode Therapeutics.
Diversification Opportunities for SeqLL and Transcode Therapeutics
0.07 | Correlation Coefficient |
Significant diversification
The 3 months correlation between SeqLL and Transcode is 0.07. Overlapping area represents the amount of risk that can be diversified away by holding SeqLL Inc and Transcode Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Transcode Therapeutics and SeqLL is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on SeqLL Inc are associated (or correlated) with Transcode Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Transcode Therapeutics has no effect on the direction of SeqLL i.e., SeqLL and Transcode Therapeutics go up and down completely randomly.
Pair Corralation between SeqLL and Transcode Therapeutics
If you would invest 39.00 in SeqLL Inc on August 29, 2024 and sell it today you would earn a total of 0.00 from holding SeqLL Inc or generate 0.0% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 0.79% |
| Values | Daily Returns |
SeqLL Inc vs. Transcode Therapeutics
Performance |
| Timeline |
| SeqLL Inc |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
| Transcode Therapeutics |
SeqLL and Transcode Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with SeqLL and Transcode Therapeutics
The main advantage of trading using opposite SeqLL and Transcode Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if SeqLL position performs unexpectedly, Transcode Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Transcode Therapeutics will offset losses from the drop in Transcode Therapeutics' long position.| SeqLL vs. Agilent Technologies | SeqLL vs. Genetic Technologies | SeqLL vs. T2 Biosystms | SeqLL vs. iSpecimen |
| Transcode Therapeutics vs. Xenetic Biosciences | Transcode Therapeutics vs. Reviva Pharmaceuticals Holdings | Transcode Therapeutics vs. Eyenovia | Transcode Therapeutics vs. Cognition Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the ETF Categories module to list of ETF categories grouped based on various criteria, such as the investment strategy or type of investments.
Other Complementary Tools
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device |